Leslie Holsinger Cortexyme, Inc. (CRTX) insider trading activity

CRTX Quotes by TradingView

Leslie Holsinger is EVP, Preclinical Development of Cortexyme, Inc.. Currently has a direct ownership of 148,080 shares of CRTX, which is worth approximately $191,023. The most recent transaction as insider was on Jun 06, 2022, when has been sold 10,920 shares (Common Stock) at a price of $2.86 per share, resulting in proceeds of $31,231. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 148K
0% 3M change
0% 12M change
Total Value Held $191,023

Leslie Holsinger Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 06 2022
SELL
Payment of exercise price or tax liability
$31,231 $2.86 p/Share
10,920 Reduced 6.87%
148,080 Common Stock
Mar 03 2022
BUY
Grant, award, or other acquisition
-
155,500 Added 49.44%
159,000 Common Stock
Dec 14 2020
SELL
Open market or private sale
$1,245,600 $31.14 p/Share
40,000 Reduced 91.95%
3,500 Common Stock
Dec 14 2020
BUY
Exercise of conversion of derivative security
$10,800 $0.27 p/Share
40,000 Added 47.9%
43,500 Common Stock
Dec 10 2020
BUY
Exercise of conversion of derivative security
$945 $0.27 p/Share
3,500 Added 50.0%
3,500 Common Stock
LH

Leslie Holsinger

EVP, Preclinical Development
South San Francisco, CA

Track Institutional and Insider Activities on CRTX

Follow Cortexyme, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRTX shares.

Notify only if

Insider Trading

Get notified when an Cortexyme, Inc. insider buys or sells CRTX shares.

Notify only if

News

Receive news related to Cortexyme, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRTX